Contract 75N93023C00011
Bolder Biotechnology Inc · Department Of Health And Human Services · June 27, 2024
Bolder Biotechnology Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 27, 2024 for $3.08 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Louisville, CO. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost-plus contract pricing. The most recent modification was on March 27, 2026. If all options are exercised, the contract could reach $3.08 million.
Contract details
- PIID
- 75N93023C00011
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Louisville, CO
- First action
- June 27, 2024
- Latest action
- March 27, 2026
Description
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
Modification timeline
-
March 27, 2026Mod P00005 · Other Administrative Action$3.08M
-
June 27, 2024Mod P00003 · Other Administrative Action$3.08M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023C00011?
Contract 75N93023C00011 is a federal contract awarded to Bolder Biotechnology Inc by Department Of Health And Human Services on June 27, 2024 for $3.08 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93023C00011?
Bolder Biotechnology Inc won contract 75N93023C00011 from Department Of Health And Human Services.
How much is contract 75N93023C00011 worth?
Contract 75N93023C00011 has obligated $0 to date but carries a potential ceiling of $3.08 million if fully funded and all options are exercised.